The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Abstract
The importance of an (auto)immune response in atherogenesis is becoming increasingly well understood. IL-17A-expressing T cells modulate immune cell trafficking, initiating inflammation and cytokine production in (auto)immune diseases. In human carotid artery plaques, we previously showed the presence of IL-17A-producing T cells and IL-23; however, IL-17A effects on atherogenesis have not been studied. Aortic root sections from 8-wk-old apolipoprotein E-deficient mice fed a standard chow diet were examined after 12 wk for lesion area, plaque composition, cellular infiltration, cytokine expression, and apoptosis. The treatment group (n = 15) received anti-IL-17A Ab and the controls (n = 10) received irrelevant Abs. Inhibition of IL-17A markedly reduced atherosclerotic lesion area (p < 0.001), maximal stenosis (p < 0.001), and vulnerability of the lesion. IL-17A mAb-treated mice showed reduced cellular infiltration, down-regulation of activation markers on endothelium and immune cells (e.g., VCAM-1), and reduced cytokine/chemokine secretion (e.g., IL6, TNFα, CCL5). To investigate possible mechanisms, different atherogenic cell types (e.g., macrophages, dendritic cells, HUVECs, vascular smooth muscle cells) were stimulated with IL-17A in addition to TNF-α, IFN-γ, or LPS to induce cellular activation or apoptosis in vitro. Stimulation with IL-17A induced proinflammatory changes in several atherogenic cell types and apoptotic cell death in murine cells. Functional blockade of IL-17A reduces atherosclerotic lesion development and decreases plaque vulnerability, cellular infiltration, and tissue activation in apolipoprotein E-deficient mice. The present data support a pathogenic role of IL-17A in the development of atherosclerosis by way of its widespread proinflammatory and proapoptotic effects on atherogenic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693 · cited 1×
“The entire aortic root, a predilection site for lesion development in apoE / mice (14), was serially sectioned and, beginning with the first slide containing all three valves, a section was stained every 75 m.”
BackgroundImmune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Vascular Adhesion Molecules in Atherosclerosis
Galkina, E., & Ley, K. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.149179 · Cited by 803
IL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium
von Hundelshausen, P., Weber, K. S. C., Huo, Y., Proudfoot, A. E. I., Nelson, P. J., Ley, K., & Weber, C. (2001) · Circulation · doi:10.1161/01.cir.103.13.1772 · Cited by 584
Davenport, P., & Tipping, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 444
Zhou, X., Paulsson, G., Stemme, S., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1216 · Cited by 413
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
Clarke, M. C. H., Littlewood, T. D., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., & Bennett, M. R. (2008) · Circulation Research · doi:10.1161/circresaha.108.175976 · Cited by 396
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Witowski, J., Pawlaczyk, K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J., Polubinska, A., Friess, H., Gahl, G. M., Frei, U., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5814 · Cited by 305
Laurat, E., Poirier, B., Tupin, E., Caligiuri, G., Hansson, G. K., Bariéty, J., & Nicoletti, A. (2001) · Circulation · doi:10.1161/01.cir.104.2.197 · Cited by 286
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H., Cravens, P. D., Racke, M. K., & Lovett-Racke, A. E. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082584 · Cited by 282
Fossiez, F., Banchereau, J., Murray, R., Van Kooten, C., Garrone, P., & Lebecque, S. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043008 · Cited by 204
IL-6 Secretion by Human Pancreatic Periacinar Myofibroblasts in Response to Inflammatory Mediators
Shimada, M., Andoh, A., Hata, K., Tasaki, K., Araki, Y., Fujiyama, Y., & Bamba, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.861 · Cited by 144
Woltman, A. M., de Haij, S., Boonstra, J. G., Gobin, S. J. P., Daha, M. R., & van Kooten, C. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11112044 · Cited by 143
Functional profile of activated dendritic cells in unstable atherosclerotic plaque
Erbel, C., Sato, K., Meyer, F. B., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0636-x · Cited by 135
Self-citationEffector Function of Resting T Cells: Activation of Synovial Fibroblasts
Yamamura, Y., Gupta, R., Morita, Y., He, X., Pai, R., Endres, J., Freiberg, A., Chung, K. C., & Fox, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2270 · Cited by 120
Smith, E. E., Stark, M. A., Zarbock, A., Burcin, T. L., Bruce, A. C., Vaswani, D., Foley, P. L., & Ley, K. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1357 · Cited by 106
Rao, D. A., Eid, R. E., Qin, L., Yi, T., Kirkiles-Smith, N. C., Tellides, G., & Pober, J. S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081661 · Cited by 86
Klingenberg, R., Nofer, J., Rudling, M., Bea, F., Blessing, E., Preusch, M. R., Gröne, H. ‐., Katus, H. A., Hansson, G. K., & Dengler, T. J. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149476 · Cited by 64
Self-citationMallat, Z., Silvestre, J., Ricousse-Roussanne, S. L., Lecomte-Raclet, L., Corbaz, A., Clergue, M., Duriez, M., Barateau, V., Akira, S., Tedgui, A., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000033592.11674.d8 · Cited by 61
Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival
Antonysamy, M. A., Fanslow, W. C., Fu, F. H., Li, W., Qian, S., Troutt, A. B., & Thomson, A. W. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01453-5 · Cited by 59
Jovanović, D., Battista, J. A. D., Martel‐Pelletier, J., Reboul, P., He, Y., Jolicoeur, F. C., & Pelletier, J. (2001) · PubMed · Cited by 47
Khallou‐Laschet, J., Caligiuri, G., Groyer, É., Tupin, E., Gaston, A., Poirier, B., Kronenberg, M., Cohen, J. L., Klatzmann, D., Kaveri, S. V., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000198401.05221.13 · Cited by 31
Preusch, M. R., Bea, F., Yang, S. H.-Y., Kreuzer, J., Isermann, B., Pedal, I., Rosenfeld, M. E., Katus, H. A., & Blessing, E. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318070c66a · Cited by 3
Self-citation
Cited by
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906
T cell subsets and functions in atherosclerosis
Saigusa, R., Winkels, H., & Ley, K. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0352-5 · Cited by 721
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Brunner, P. M., Guttman-Yassky, E., & Leung, D. Y. M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.011 · Cited by 642
Metadata
- Authors
- Erbel, C., Chen, L., Bea, F., Wangler, S., Celik, S., Lasitschka, F., Wang, Y., Böckler, D., Katus, H. A., & Dengler, T. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12
- Volume
- 183
- Issue
- 12
- Pages
- 8167-8175
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2117758842
- Cited by
- 358
- References
- 38
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.